NHS Tayside Sign Up to Early Warning System Miya Observations

Alcidion LtdNHS Tayside has signed a five-year agreement with smart health tech provider Alcidion to deploy Miya Observations, an electronic monitoring system that will help thousands of busy healthcare professionals as they care for patients.

Formerly known as Patientrack, the system has already delivered substantial clinical benefits in other NHS hospitals, including early adopters in Scotland, where alerts provided by the system and improved visibility of the sickest patients, have helped staff to significantly enhance patient safety and cut cardiac arrests.

NHS Tayside, which employs 14,000 people and serves a population of more than 400,000 across rural and urban communities in Dundee City, Angus and Perth and Kinross, will deploy Miya Observations throughout its regional network.

Miya Observations provides an early warning system that shares critical information as soon as it is recorded, rather than simply passively capturing a patient’s vital signs on a paper-based bedside chart. The system alerts clinical staff when patients show signs of deterioration, so healthcare professionals can rapidly intervene and focus on those patients immediately in need. It has helped hospitals to prevent negative clinical outcomes and to manage risks around deadly conditions including acute kidney injury and sepsis. Hospitals using the system have observed reduced length of stay and many other benefits.

NHS Tayside will use Miya Observations across approximately 975 beds to electronically record vital signs and patient observations, produce charts, automatically calculate patient early warning scores, generate clinical alerts, and document a range of clinical assessments.

Alcidion UK Commercial Director Tom Scott said: "We are thrilled to be partnering with NHS Tayside, extending Miya Observations to a third health board in Scotland. This agreement represents recognition of the benefits that are realised through capturing key clinical data at the bedside, and reporting and acting on it in real time."

Alcidion Group Managing Director Kate Quirke said: "Healthcare technology should exist to deliver benefits to the people delivering and receiving care. It should help to make the right thing to do the easiest thing to do. I look forward to seeing these benefits extend to healthcare professionals and patients in NHS Tayside as the health board deploys Alcidion’s Miya capabilities. It is rewarding to see this success story continue to grow in Scotland, and to be welcoming another important NHS customer in the UK."

About NHS Tayside

Tayside Health Board was established in April 1974 and is responsible for commissioning health care services for the residents in the geographical local government areas of Angus, Dundee and Perth and Kinross.

The Board's boundaries are coterminous with these local government areas, which had a combined population of 416,090 based on mid-year 2017 population estimates published by National Records of Scotland.

NHS Tayside's governance includes three major and a number of community hospitals, including the University of Dundee's Medical School attached to the regions flagship institute, Ninewells Hospital in Dundee. It also includes over 60 GP surgeries and a variety of health centres staffed by thousands of employees of the health region.

About Alcidion

Alcidion Group Limited (Alcidion) has a simple purpose, that is, to transform healthcare with proactive, smart, intuitive technology solutions that improve the efficiency and quality of patient care in healthcare organisations, worldwide.

Alcidion offers a complementary set of software products and technical services that create a unique offering in the global healthcare market. Based on the flagship product, Miya Precision, the solutions aggregate meaningful information to centralised dashboards, support interoperability, facilitate communication and task management in clinical and operational settings and deliver Clinical Decision Support at the point of care; all in support of Alcidion’s mission to improve patient outcomes.

Since listing on the ASX in 2011, Alcidion has acquired multiple healthcare IT companies and expanded its foothold in the UK, Australia, and New Zealand to now service over 300 hospitals and 60 healthcare organisations, with further geographical expansion planned.

With over 20 years of healthcare experience, Alcidion brings together the very best in technology and market knowledge to deliver solutions that make healthcare better for everyone.

Most Popular Now

Integrating Care Records is Good. Using …

Opinion Article by Dr Paul Deffley, Chief Medical Officer, Alcidion. A single patient record already exists in the NHS. Or at least, that’s a perception shared by many. A survey of...

AI could Help Pathologists Match Cancer …

A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and collaborators, suggests that artificial intelligence (AI) could significantly improve how...

Should AI Chatbots Replace Your Therapis…

The new study exposes the dangerous flaws in using artificial intelligence (AI) chatbots for mental health support. For the first time, the researchers evaluated these AI systems against clinical standards...

AI Detects Early Signs of Osteoporosis f…

Investigators have developed an artificial intelligence-assisted diagnostic system that can estimate bone mineral density in both the lumbar spine and the femur of the upper leg, based on X-ray images...

AI Sharpens Pathologists' Interpret…

Pathologists' examinations of tissue samples from skin cancer tumours improved when they were assisted by an AI tool. The assessments became more consistent and patients' prognoses were described more accurately...

AI Tool Detects Surgical Site Infections…

A team of Mayo Clinic researchers has developed an artificial intelligence (AI) system that can detect surgical site infections (SSIs) with high accuracy from patient-submitted postoperative wound photos, potentially transforming...

Forging a Novel Therapeutic Path for Pat…

Rett syndrome is a devastating rare genetic childhood disorder primarily affecting girls. Merely 1 out of 10,000 girls are born with it and much fewer boys. It is caused by...

Meet Your Digital Twin

Before an important meeting or when a big decision needs to be made, we often mentally run through various scenarios before settling on the best course of action. But when...

NHS National Rehabilitation Centre to De…

The new NHS National Rehabilitation Centre will deploy technology to help patients to maintain their independence as they recover from life-changing injuries and illnesses and regain quality of life. Airwave Healthcare...

AI Finds Hundreds of Potential Antibioti…

Snake, scorpion, and spider venom are most frequently associated with poisonous bites, but with the help of artificial intelligence, they might be able to help fight antibiotic resistance, which contributes...

AI Tool Accurately Detects Tumor Locatio…

An AI model trained to detect abnormalities on breast MR images accurately depicted tumor locations and outperformed benchmark models when tested in three different groups, according to a study published...

AI can Accelerate Search for More Effect…

Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer’s disease drug. They found the drug slowed cognitive decline by 46% in...